ArticleInternal medicine (Tokyo, Japan)2026

Low Generic Drug Penetration for Expensive Oral Molecular Targeted Agents: An Experience with Generic Imatinib in Japan.

Keisuke Kidoguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.